Meeting
2020 Genitourinary Cancers Symposium
Cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI) or targeted therapy (TT): A propensity score-based analysis.
Presenter
Ziad Bakouny, MD, MSc
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
General Session
Session Title
Developing Management Options in Metastatic Renal Cell Carcinoma
Track
Renal Cell Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 608)
Abstract #
608
Abstract Disclosures
Similar Videos & Slides
Speaker: Roselle B. De Guzman, MD
Videos & Slides
2011 Genitourinary Cancers Symposium
Postoperative complications from cytoreductive nephrectomy after neoadjuvant targeted therapy for metastatic renal cell carcinoma.
Speaker: Brian Francis Chapin, MD
Speaker: Panel Discussion
Speaker: Sana Al-Sukhun